BioPharma Dive
DECEMBER 10, 2023
A new sickle cell disease therapy developed by CRISPR Therapeutics and Vertex Pharmaceuticals is now approved in the U.S. and U.K. This is the story of how it came to be.
EMCrit Project
DECEMBER 10, 2023
Within the past year, two major societies have released guidelines on ARDS: the ATS (American Thoracic Society) and the ESICM (European Society of Intensive Care Medicine). Don’t be fooled by their names – both of these organizations are fundamentally international in scope. Some authors on the ATS document were from Europe, and similarly some authors […] EMCrit Project by Josh Farkas.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Med Ed 101
DECEMBER 10, 2023
This article will discuss two of the three commonly used non-stimulant medications for the management of ADHD and ADHD-related symptoms. We will primarily focus on comparing clonidine versus guanfacine in pediatric patients. As pharmacies deal with shortages of more and more stimulant medications commonly used to treat ADHD in children, it may come up more […] The post Clonidine Versus Guanfacine: ADHD Management appeared first on Med Ed 101.
Drug Patent Watch
DECEMBER 10, 2023
In the ever-evolving landscape of the biotech and pharmaceutical sectors, accurate valuation of post-revenue drug assets stands as the linchpin for informed and strategic decision-making. The significance of this valuation… The post Decoding Pfizer’s Portfolio: A New Model for Precision in Pharma Investments appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Dive
DECEMBER 10, 2023
While new gene therapies for the blood disease grabbed headlines at ASH, Pfizer presented fresh data for an oral drug meant to build on its marketed therapy Oxbryta.
Pharmaceutical Business Review
DECEMBER 10, 2023
AML is a fast-developing cancer originating in the blood and bone marrow, impacting myeloid cells that typically transform into different types of mature blood cells. REZLIDHIA is a selective, potent, oral, small-molecule inhibitor of mutated IDH1 (mIDH1) intended for binding and inhibiting mIDH1 to reduce 2-hydroxyglutarate levels and restore normal cellular differentiation of myeloid cells.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaTech
DECEMBER 10, 2023
Ashland has launched Viatel™ ultrapure bioresorbable polymers (lactide / glycolide / caprolactone chemistries), a higher purity platform of controlled release polymers used in long acting injectables and implants (LAII). Ultrapure provides improved release consistency, extended-release durations and are better suited for sensitive drug compounds due to the less acidic micro-environment.
RX Note
DECEMBER 10, 2023
Introduction Opposite to constipation , diarrhoea refers to an increase in frequency of the passage of abnormally soft or watery stools relative to the usual bowel for that individual. It is usually a symptom of gastrointestinal infection, which can be caused by a variety of bacterial, viral and parasitic organisms. Most patients will present to the community pharmacy with a self-diagnosis of acute diarrhoea (rapid onset, lasts 14 days) - Crohn's disease?
Pharmacy Joe
DECEMBER 10, 2023
In this episode, I’ll discuss the AHA/NCS scientific statement on critical care management of patients after cardiac arrest. Episode 877: Sedation and Analgesia Statements From the AHA/NCS Scientific Statement on Critical Care Management of Patients After Cardiac Arrest Subscribe on iTunes , Android , or Stitcher There is a lack of high-quality published research to support the critical care management of patients after cardiac arrest, and as a result there are few guideline recommendations in t
Drug Patent Watch
DECEMBER 10, 2023
Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs. This is one of the longest exclusivity terms provided by… The post Pharmaceutical companies with the most ‘New Chemical Entity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
PharmExec
DECEMBER 10, 2023
Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.
Pharmacy Times
DECEMBER 10, 2023
The study results shine a light on the potential need for further policy changes that promote gender equity and bridge the gap in R01 funding awarded to female applicants.
The Guardian - Pharmaceutical Industry
DECEMBER 10, 2023
Proposed merger with smaller competitor Sigma and stock market listing would unlock billions of dollars for founders of discount pharmacy chain Chemist Warehouse Follow our Australia news live blog for latest updates Get our morning and afternoon news emails , free app or daily news podcast Chemist Warehouse will become a publicly traded company through a merger with Sigma Healthcare, creating a retailing giant and unlocking billions of dollars for the founders of the discount pharmacy chain.
Pharmacy Times
DECEMBER 10, 2023
Median overall survival is set to be more than 2 years, which is more than double the overall survival of current frontline therapies.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
GMPSOP
DECEMBER 10, 2023
Steps required to control packaging materials in pharmaceutical Pharmaceuticals quality assurance & validation procedures GMPSOP Steps required to control packaging materials in pharmaceutical Last Updated on December 10, 2023 Prev PREVIOUS POST Table of Contents Pharmaceutical manufacturers implement numerous processes to control packaging materials to avoid costly mix-ups.
Pharmacy Times
DECEMBER 10, 2023
He also provides insight for students training in classical hematology, oncology hematology, or oncology pharmacy.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for United Laboratories International here.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.
Pharmacy Times
DECEMBER 10, 2023
This is the first trial to show that a MRD-guided approach with treatment beyond MRD negativity has a significant advantage over chemotherapy, both in terms of PFS and OS.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Hisamitsu Pharmaceutical here.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Daewoong here.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Almirall here.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Otsuka here.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Lupin here.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Cipla here.
Expert insights. Personalized for you.
142 
Let's personalize your content